Other

Remainder of Fiscal Year 2024

Moderna Remainder of Fiscal Year 2024 increased by 291.7% to $47.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $47.00M to $47.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2020
Last reportedQ1 2026May 1, 2026
Metric ID: remainder_2024

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$9.00M$7.00M$41.00M$23.00M$11.00M$31.00M$20.00M$6.00M$55.00M$38.00M$17.00M$47.00M$29.00M$12.00M$47.00M
QoQ Change-22.2%+485.7%-43.9%-52.2%+181.8%-35.5%-70.0%+816.7%-30.9%-55.3%+176.5%-38.3%-58.6%+291.7%
YoY Change+155.6%+57.1%-24.4%-13.0%-45.5%+77.4%+90.0%+183.3%-14.5%-23.7%-29.4%+0.0%
Range$6.00M$55.00M
CAGR+60.4%
Avg YoY Growth+34.4%
Median YoY Growth-6.5%

Remainder of Fiscal Year 2024 at Other Companies

Frequently Asked Questions

What is Moderna's remainder of fiscal year 2024?
Moderna (MRNA) reported remainder of fiscal year 2024 of $47.00M in Q1 2026.
How has Moderna's remainder of fiscal year 2024 changed year-over-year?
Moderna's remainder of fiscal year 2024 decreased by 0.0% year-over-year, from $47.00M to $47.00M.